BRANDY TREVINO: Open Payments
NPI 1851744957 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 8 payments from 7 companies in 2025. Trend: 2023 $377 · 2024 $886 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $212 |
| Insulet Corporation | 1 | $145 |
| Dexcom, Inc. | 1 | $143 |
| Amgen Inc. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $102 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Biocomposites Inc | 1 | $17 |
Products named: OMNIPOD, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, EVENITY, GATTEX, ETERNA, Zilretta, Stimulan.
Industry payments across TX — which companies pay providers there.
